IL0011407140
IL0011407140
UroGen Pharma Ltd.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.8B EUR | 1.8B EUR | 875.77M EUR | 1.13B EUR |
Enterprise Value | 1.9B EUR | 1.92B EUR | 960.98M EUR | 1.15B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 13.18x | -- | -- | -- |
Price to Sales | 9.54x | 9.53x | 6.23x | 12.65x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 10.05x | 10.15x | 6.84x | 12.84x |
EV/EBITDA | -28.57x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -5.94% | -8.85% | -18.96% | -10.66% |